BENNETT J CLAUDE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Feb 9, 2005
Insider Transaction Report
Form 4
BENNETT J CLAUDE
DirectorPresident
Transactions
- Exercise/Conversion
Common Stock
2005-02-07$0.87/sh+1,219$1,061→ 19,469 total - Exercise/Conversion
Stock Option
2005-02-07$3.59/sh−636$2,283→ 402,669 totalExercise: $3.59From: 2002-12-12Exp: 2012-12-11→ Common Stock (636 underlying) - Exercise/Conversion
Common Stock
2005-02-07$1.04/sh+104$108→ 18,250 total - Exercise/Conversion
Common Stock
2005-02-07$3.59/sh+636$2,283→ 17,387 total - Exercise/Conversion
Common Stock
2005-02-07$1.18/sh+759$896→ 18,146 total - Exercise/Conversion
Stock Option
2005-02-07$1.04/sh−104$108→ 401,806 totalExercise: $1.04From: 2003-12-11Exp: 2013-12-10→ Common Stock (104 underlying) - Exercise/Conversion
Stock Option
2005-02-07$0.87/sh−1,219$1,061→ 400,587 totalExercise: $0.87From: 2003-02-03Exp: 2013-02-03→ Common Stock (1,219 underlying) - Exercise/Conversion
Stock Option
2005-02-07$1.18/sh−759$896→ 401,910 totalExercise: $1.18From: 2003-08-05Exp: 2013-08-04→ Common Stock (759 underlying)